Control of bacterial infections in cultured fish and shellfish by means or bacteriophages
通过噬菌体控制养殖鱼类和贝类的细菌感染
基本信息
- 批准号:12660171
- 负责人:
- 金额:$ 2.24万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:2000
- 资助国家:日本
- 起止时间:2000 至 2001
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Bacteriophages (phages) as specific pathogen-killers are expected as agents for controlling fish bacterial infections, but little attention has been paid for phage therapy and prophylaxis of bacterial infections of fish and shellfish. The present study was conducted to examine a possibility of phage-therapy in aquaculture and results are summarized as follows:1. Lactococcus garvieae, the causative agent of streptococcal infection in cultured yellowtail Seriola quinqueradiata, consisted of a major phage type (phages : Siphoviridae). When experimentally infected fish with L. garvieae received intraperitoneally or orally administered anti-L. garvieae phages, fish showed significantly lower mortality compared with control fish without phage administrations2. Pseudomonas plecoglossicida, the causative agent of bacterial hemorrhagic ascites in cultured ayu Pleooglossus altivelis consisted of a single phage type (phages : Myoviridae and Podoviridae). Oral administration of phage-impregnated feed to ayu increased resistance against experimental infection with P. plecoglossicida. When phage-therapy was evaluated under cohabitation conditions with fish which had been previously infected with P. plecogolssicida, phage-received fish showed significantly lower mortality than that of untreated control fish. Interestingly, phage-resistant variants of P. plecogolssicida exhibited no virulence to ayu. A field phage therapy reduced markedly mortalities of ayu due to P. plecogolssicida infection. Throughout the field therapy, neither phage-resistant P. plecogolssicida were detected from fish, nor phageneutrahzing antibodies were detected from fish.3. Similar result was also obtained in phage-therapy experiments on Vibrio splendidus biovar II infection of larvae Japanese oyster Crassostrea gigas, though the phage type (phages : Podoviridae) of this pathogen was not single.These results suggest that it may be possible to use phages to control the diseases in the aquaculture field.
噬菌体作为特异的病原菌杀灭剂被认为是控制鱼类细菌感染的有效药物,但对鱼类和贝类细菌感染的治疗和预防却鲜有人关注。本研究旨在探讨噬菌体疗法在水产养殖中应用的可能性,主要结果如下:1.在养殖的西洋参中,引起链球菌感染的致病菌是一种主要的噬菌体类型(噬菌体:链状病毒科)。当实验感染加维氏乳杆菌的鱼接受腹腔或口服抗L.与未投喂噬菌体的对照鱼相比,加毒噬菌体的鱼的死亡率显著降低。高山阿鱼细菌性出血性腹水的病原菌为单噬菌体(Myoviridae和Podoviridae)。口服噬菌体浸渍饲料提高了对舌疫霉菌实验感染的抵抗力。当噬菌体治疗在与先前感染了P.plecogolssicida的鱼共存的条件下进行评估时,接受噬菌体治疗的鱼的死亡率显著低于未处理的对照鱼。有趣的是,抗噬菌体变异体对AYU没有表现出毒力。一种田间噬菌体疗法显著降低了由P.plecogolssicida感染引起的阿育的死亡率。在整个田间治疗过程中,没有从鱼中检测到抗噬菌体的Plecogolssicida,也没有从鱼中检测到吞噬细胞抗体。用噬菌体治疗日本牡蛎幼虫感染太平洋弧菌生物群II也得到了类似的结果,但该病原菌的噬菌体类型(噬菌体:Podoviridae)并不是单一的,这些结果表明利用噬菌体来控制养殖现场的病害是可能的。
项目成果
期刊论文数量(9)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakai T.: "Protective effects of bacteriophage on experimental Lactococcus garvieae infection in yellowtail"Diseases of Aquatic Organisms. 37. 33-41 (1999)
Nakai T.:“噬菌体对黄尾鱼实验性加氏乳球菌感染的保护作用”水生生物疾病。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Park S.-C.: "A brown pigment-producing strain of Pseudomonas plecoglossicida isolated from ayu with hemorrhagic ascites"Fish Pathology. 35. 91-92 (2000)
Park S.-C.:“从患有出血性腹水的香鱼中分离出一种产生棕色色素的假单胞菌菌株”《鱼类病理学》。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Nakai T.: "Bacteriophage therapy of infectious diseases in aquaculture"Research in Microbiology. 153. 13-18 (2002)
Nakai T.:“水产养殖传染病的噬菌体疗法”微生物学研究。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ooyama T., Hirokawa Y., Minami T., Yasuda H., Nakai T., Endo M., Ruangpan., Yoshida T.: "Cell surface properties of Lactococcus garvieae strains and their immunogenicity in yellowtail, Seriola quinqueradiata."Diseases of Aquatic Organisms. (印刷中). (2002)
Ooyama T.、Hirokawa Y.、Minami T.、Yasuda H.、Nakai T.、Endo M.、Ruangpan.、Yoshida T.:“加维乳球菌菌株的细胞表面特性及其在鰤鱼中的免疫原性。”疾病水生生物(2002 年)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ooyama T.: "Cell surface properties of Lactococcus garvieae strains and their immunogenicity in yellowtail, Seriola quinqueradiata"Diseases of Aquatic Organisms. (印刷中). (2002)
Ooyama T.:“鰤鱼乳球菌菌株的细胞表面特性及其免疫原性”水生生物疾病(2002 年出版)。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NAKAI Toshihiro其他文献
NAKAI Toshihiro的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NAKAI Toshihiro', 18)}}的其他基金
Establishment of an infectious RNA transcription system for piscine nodaviruses and molecular analyses of the pathogenicity
鱼类诺达病毒感染性RNA转录系统的建立及其致病性分子分析
- 批准号:
14360110 - 财政年份:2002
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Control of viral nervous necrosis in merine fish
浅海鱼病毒性神经坏死的控制
- 批准号:
05454094 - 财政年份:1993
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
The establishment of basic technology for next-generation phage therapy using metagenomics and synthetic biology
利用宏基因组学和合成生物学建立下一代噬菌体治疗的基础技术
- 批准号:
22KJ1099 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Investigating phage therapy for the treatment of urinary tract infections
研究噬菌体疗法治疗尿路感染
- 批准号:
10677257 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Towards phage therapy: combining genetics and cutting edge CryoEM to optimise a bacterial virus to kill a superbug
迈向噬菌体疗法:结合遗传学和尖端冷冻电镜来优化细菌病毒以杀死超级细菌
- 批准号:
2902040 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
Mining the phage playbook to create a potent, generic phage therapy
挖掘噬菌体剧本以创建有效的通用噬菌体疗法
- 批准号:
10723647 - 财政年份:2023
- 资助金额:
$ 2.24万 - 项目类别:
Developing phage therapy to reduce plant pathogen virulence
开发噬菌体疗法以降低植物病原体毒力
- 批准号:
2752148 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
Ensuring the Success of Phage Therapy: Identifying and Characterizing Antiphage Defence in the Human and Aquacultural Pathogen Vibrio parahaemolyticus
确保噬菌体治疗的成功:识别和表征人类和水产养殖病原体副溶血弧菌中的抗噬菌体防御
- 批准号:
472056 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Fellowship Programs
Developing generalized engineering tools to create enhanced phage therapy for the clinic and commercialization
开发通用工程工具,为临床和商业化创建增强型噬菌体疗法
- 批准号:
10670407 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Developing a national capacity for adjunctive phage therapy to treat antibiotic-resistant respiratory infections through Citizen Science. (Ref: 4214)
通过公民科学发展国家辅助噬菌体疗法治疗耐抗生素呼吸道感染的能力。
- 批准号:
2720244 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Studentship
Phage Therapy to Reduce AMR Enterobacteria Spread from a One Health Perspective
从单一健康角度减少抗菌素耐药性肠杆菌传播的噬菌体疗法
- 批准号:
MR/W031248/1 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别:
Research Grant
Developing generalized engineering tools to create enhanced phage therapy for the clinic and commercialization
开发通用工程工具,为临床和商业化创建增强型噬菌体疗法
- 批准号:
10484210 - 财政年份:2022
- 资助金额:
$ 2.24万 - 项目类别: